ERcast: Clinical Perspectives Podcast Preview
The summary below is from an episode of ERcast: Clinical Perspectives
Initial opioid choice may shift risk in different directions: hydrocodone tracks more with subsequent chronic use, while oxycodone tracks more with later overdose. For acute pain prescribing, the bigger durable signal is still dose and quantity, especially at higher total morphine milligram equivalents.
Hydrocodone Versus Oxycodone Risks
- Divergent risk pattern: Among opioid-naive adults, hydrocodone was more associated with first-year chronic use after adjustment, while oxycodone carried a higher subsequent overdose risk.
- Overdose signal with oxycodone: The overdose difference favored hydrocodone, with oxycodone linked to about a 65% higher adjusted hazard of fatal or nonfatal overdose after the index prescription.
- Chronic use definition: The study used a strict utilization marker for chronic use: more than 6 opioid prescriptions in the first year with minimal uncovered days between fills.
- Absolute risk perspective: Most patients did not develop chronic use or overdose after a first short course, and that low baseline risk matters when discussing opioid harms at the bedside.
- Dose and quantity matter most: Total prescribed MME remains the more actionable lever; index prescriptions above 300 MME have been linked to roughly 4-fold higher odds of chronic use. We get into the prescribing implications in the episode.
Practical Opioid Prescribing Takeaways
- Small initial prescriptions: Prior evidence consistently supports shorter courses and fewer tablets for acute pain, rather than assuming one specific opioid is categorically safer.
- Likeability score skepticism: Choosing an opioid because patients like it less is not clearly patient-centered, and preference alone is a weak surrogate for addiction or overdose risk.
- Chronic use is imperfect: Long-term opioid use is not synonymous with opioid use disorder; some patients on chronic opioids never develop misuse, addiction, or overt abuse.
- Shared decision framing: When opioids are appropriate, frame risk around dose, quantity, and follow-up rather than implying that any single short prescription will start an inevitable path to OUD.
Subscribe to ERcast: Clinical Perspectives to listen to the episode.
Faculty
- Matthew DeLaney, MD, FACEP, FAAEM
Dr. Matthew DeLaney is an emergency medicine physician and educator based in Birmingham, Alabama. A native of Mobile, he earned his medical degree from the University of South Alabama and completed his emergency medicine residency at Maine Medical Center.Dr. DeLaney has experience in both community and academic emergency medicine and is known for his commitment to teaching and medical education. He lives in Birmingham with his wife, Erin, who is also a physician, and their two daughters.
- Charles Khoury MD, FACEP, FAAEM